Contents

Current Cancer Drug Targets, Volume 6 - Number 3

Spectrum of Radiopharmaceuticals in Nuclear Oncology

, 6(3): 181 - 196

Delphine Denoyer, Nathalie Perek, Nathalie L. Jeune and Francis Dubois


DOI: 10.2174/156800906776842984




γ-H2AX as a Therapeutic Target for Improving the Efficacy of Radiation Therapy

, 6(3): 197 - 205

J. Kao, M. T. Milano, A. Javaheri, M. C. Garofalo, S. J. Chmura, R. R. Weichselbaum and S. J. Kron


DOI: 10.2174/156800906776842957




Molecular Targets of Ovarian Carcinomas with Acquired Resistance to Platinum/Taxane Chemotherapy

, 6(3): 207 - 227

Christian Kurzeder, Georg Sauer and Helmut Deissler


DOI: 10.2174/156800906776842975




Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment

, 6(3): 229 - 244

Xiaohui Zhang, Santo V. Nicosia and Wenlong Bai


DOI: 10.2174/156800906776842939




Specialisation of the Tropomyosin Composition of Actin Filaments Provides New Potential Targets for Chemotherapy

, 6(3): 245 - 256

Justine R. Stehn, Galina Schevzov, Geraldine M. O'Neill and Peter W. Gunning


DOI: 10.2174/156800906776842948




Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

, 6(3): 257 - 269

M. M. Marelli, R. M. Moretti, J. Januszkiewicz-Caulier, M. Motta and P. Limonta


DOI: 10.2174/156800906776842966




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science